Adipotide FTPP Supplier China: Wholesale Guide

Lock the complete Adipotide construct

Write the controlled name, complete sequence or molecular reference, cyclization, linker, D-residue or other modifications where applicable, termini, form, target purity, strength, quantity and Research Use Only status. Map Adipotide and FTPP as controlled synonyms only after the exact construct is confirmed. Require the supplier to use a consistent SKU on the quote, COA, analytical sample, vial label and packing list. A shortened name, CAS entry or product photograph cannot replace the full technical identity.

Compare 2mg, 5mg, 10mg and 16mg formats

Build a matrix with product code, strength, vial count, units per kit, total nominal material, content tolerance, parent lot, finished lot and price basis. Ask whether the four strengths share a parent lot and how filling genealogy and reconciliation are retained. One 10mg vial is not operationally equivalent to two 5mg vials because packaging and filling controls differ. Prohibit silent strength substitutions and compare offers by total documented Adipotide material rather than vial or kit count alone.

Review identity against every modification

Require batch-linked HPLC and mass-spectrometry evidence suitable for the specified construct. Check expected and observed molecular information, sample ID, complete chromatogram, integration, method reference, dates, report number and authorization. Ask how the analytical strategy supports the linker, cyclic or stereochemical features in the approved specification and what its limitations are. A high HPLC result cannot by itself establish every modification, exact content or the absence of all possible sequence-related impurities.

Verify content independently of purity

Ask which suitable quantitative method or controlled filling record supports each 2mg, 5mg, 10mg or 16mg label and what tolerance applies. Clarify whether the amount means net target material or total lyophilized mass including salts, water or excipients. If one parent lot is divided between formats, obtain reconciliation of issued, filled, rejected and remaining quantities. Keep construct identity, chromatographic purity and quantitative content as independent acceptance fields so one result is not extended beyond its method scope.

Qualify claims, documents and repeat supply

Avoid clinical, dosing or consumer claims and keep the supply channel explicitly research-only. Map the legal seller, synthesis site, laboratory, filler, release authority, stock owner and shipper. Confirm released stock, MOQ per strength, document timing, packaging and change notification. Require the COA, analytical attachments, SDS, specification, labels, invoice and packing list to agree. Review every new lot and score actual document accuracy, delivery and corrective response instead of approving an entire catalog.

Build one comparable wholesale RFQ matrix

Send every candidate the same fields: controlled identity, strength, vial count, total material, target purity or composition, identity method, quantitative-content basis, offered lot, testing status, packaging, documents, MOQ, lead time and shipping term. Mark missing answers as exceptions instead of filling gaps with assumptions. Separate testing, setup, customization and transport costs from recurring unit price. A standardized matrix gives scientific, purchasing and quality reviewers one auditable record and prevents an incomplete offer from appearing cheaper simply because it describes less work.

Apply a batch-focused quality-control review

Define every required attribute, acceptance criterion, method and record before purchase. Use the quality-control framework to connect each supplier claim to evidence and its method scope. Check sample identifiers, dates, report numbers, units and lot relationships across the complete reports. Batch-specific evidence is more decision-useful than a representative certificate. Preserve original files, record revisions and investigate contradictions before approving shipment. Where risk warrants, arrange independent testing under a documented sampling and custody plan.

Create a documentation gate before dispatch

List the required batch COA, analytical attachments, SDS, specification, supported storage statement, label proof, invoice and packing list in the RFQ and purchase order. Reconcile product, strength, lot, quantity and revision across records with the documentation guide. Require replacement documents when the offered lot changes. The importer remains responsible for current destination requirements. Research-use wording improves clarity but cannot guarantee customs entry or replace destination-specific legal and broker review.

Verify supplier and batch ownership

Document the legal seller, manufacturing site, analytical laboratory, filling or packaging site, inventory owner, release authority and dispatch entity for the exact SKU. A trading or coordination company can work with qualified partners, but roles and accountability must be transparent. Ask who owns the batch record, authorizes release, handles deviations and provides corrective action. Require advance notification when a critical party changes. Business-registration evidence supports identity but does not replace technical qualification of the offered lot.

Plan logistics and receiving controls

Confirm dispatch location, carrier, shipping term, packaging configuration and realistic production, release and transit windows. Reject guarantees of customs clearance or misleading declarations. On receipt, document package condition, seals, product, strength, lot and quantity, then connect internal inventory to the supplier batch. Store according to the applicable approved specification and quarantine unexplained damage, label conflicts, quantity differences or excursions until a documented quality decision is completed.

Use actual performance for repeat-order approval

A controlled evaluation order should use the same specification and evidence expectations planned for wholesale scale. Assess document accuracy, packaging, delivery time, communication and corrective response. Update a supplier scorecard from observed performance rather than catalog breadth or claims. For every new lot, repeat the batch review and approve current documents before dispatch. Require notification before changes to material specification, manufacturing, testing, filling, labels, packaging or other buyer-approved conditions.

Related products and same-category guides

• Adipotide FTPP 2mg
• Adipotide FTPP 5mg
• Adipotide FTPP 10mg
• Adipotide FTPP 16mg
• AOD-9604 Supplier Guide
• Third-Party Testing Guide

Frequently asked questions